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Abstract The RPE65 protein appears late during the retinal
development. To study the basis for this regulation, the rat
RPE65 cDNA was sequenced and the mRNA subsequently
quantitated at various stages by competitive RT-PCR. RPE65
mRNA was detected as early as E18 (36 copies/ng of whole eye
total RNA). It gradually accumulates up to P12 (27 000 copies/
ng) at which point it reaches a steady state level. This increase is
interrupted for 3 days (P2^P4) during which the levels of mRNA
remain stable. This timing and rate of accumulation parallels
that of rat and mouse opsin mRNA and suggests that common
factors may control the activation of genes in photoreceptors and
retinal pigment epithelium cells.
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1. Introduction
The retinal pigment epithelium (RPE) is a pigmented single
cell-layered tissue interposed between the vascular-rich cho-
roid and the neural retina. This ocular tissue is in close con-
tact with the photoreceptor rod and cone outer segments,
extending its microvilli through the interphotoreceptor matrix
around the outer segments. Among the many roles of the
RPE cell which have been characterized, the periodic phago-
cytosis of the outer segment tips [1] and retinol metabolism [2]
are essential to the visual process. In fact, it is in the RPE that
critical steps of the visual cycle of retinoids [3] are performed,
including the esteri¢cation of the all-trans-retinol that results
from the bleaching of the photopigment, rhodopsin, and the
isomerization of the retinyl ester to 11-cis-retinol and oxida-
tion to 11-cis-retinal [4^6].
RPE65 is an abundant 65-kDa microsomal RPE-speci¢c
protein conserved in vertebrates [7^10]. Although the function
of RPE65 remains unknown, several observations indicate
that this protein is an enzyme involved in the RPE-speci¢c
metabolism of 11-cis-retinol [11]. Recent ¢ndings of mutations
in the RPE65 gene causing severe, childhood-onset retinal
dystrophy indicate that RPE65 defects dramatically a¡ect
photoreceptor survival and further point to the critical role
of RPE65 in RPE physiology [12,13].
We previously showed that RPE65 expression is develop-
mentally regulated [14]. Using monoclonal antibody RPE9 on
tissue sections of rat retina [15], we found that RPE65, which
is constantly expressed in adult animals, appears in RPE cells
only at postnatal days 4^5, whereas earlier expression could
be expected since many RPE cells exhibit a di¡erentiated phe-
notype by embryonic day 18 [16]. This late expression raised
the question of a delayed transcriptional activation of the
RPE65 gene. In addition, because this timing coincides with
the appearance of the ¢rst photoreceptor outer segment mem-
branes [17,18], a coordinated developmental expression of
RPE65 with certain photoreceptor-speci¢c proteins was pos-
sible. In order to examine when the RPE65 gene is turned on,
we quanti¢ed RPE65 mRNA during retinal development by
competitive RT-PCR. As a prerequisite to this study, the rat
RPE65 cDNA was sequenced.
2. Materials and methods
2.1. Materials
Restriction and modi¢cation enzymes, oligonucleotides and agarose
were from Eurogentec (Seraing, Belgium). The guanidine thiocyanate
solution (RNAXEL) and glass beads (RNABIND) were from Euro-
bio (Les Ulis, France). Proteinase K was obtained from Merck
(Darmstadt, Germany). RNase blocker and sequencing primers for
pUC-derived plasmids were from Promega (Madison, WI, USA).
2.2. RNA extractions
Eyes from adult Wistar rats were homogenized with a motor-driven
homogenizer at 1000 rpm for 1 min in a guanidine thiocyanate sol-
ution [19]. Total RNA was then extracted following the APCG single-
step method [19] and puri¢ed on glass beads. For the construction of
the retina+RPE library, whole eyes from 12-day-old Wistar rats were
incubated in a 0.1% proteinase K solution in Hanks’ balanced salt
solution at 37‡C for 15 min and the retina+RPE dissected out accord-
ing to Sakagami et al. [20]. RNA from this tissue was then extracted
as described above.
For the quantitation of the RPE65 mRNA during the development,
whole eyes from Wistar rats at embryonic days (E) 17, 19 and 20 and
from postnatal days (P) 1^8 as well as from P10, P12, P15, P20 and
P25 were enucleated, weighed, and the total RNA extracted as above.
All RNAs were quanti¢ed by UV spectrophotometry. Only those with
a V260/V280 ratio higher than 1.80 were retained and stored at 370‡C
in DEPC-treated H2O for a maximum of 6 months. Quality of RNAs
from di¡erent developmental stages was veri¢ed by Northern blot
hybridized with a digoxigenin-labeled glyceraldehyde 3-phosphate de-
hydrogenase riboprobe.
2.3. cDNA cloning and sequencing
To obtain the open reading frame of the rat RPE65 cDNA, 2 Wg of
total RNA from whole eyes was reverse transcribed. Because of the
high level of identity between the rat and bovine RPE65 cDNA cod-
ing sequences, couples of 20-mer primers matching the bovine RPE65
cDNA sequence [7] could be used to amplify most of the rat RPE65
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open reading frame. Ampli¢ed cDNA fragments were puri¢ed
and directly sequenced in both directions with the PCR primers.
To obtain the 5P and 3P ends of the RPE65 cDNA, we generated a
rat retina+RPE library in Vgt11 with the CapFinder PCR cDNA
library construction kit (Clontech, CA, USA) and screened it by
PCR using cDNA-speci¢c and plasmid primers. The cDNA frag-
ments were puri¢ed on agarose gels, cloned into pCR-Script (Strata-
gene) and sequenced in both directions using vector and internal
primers.
2.4. Competitive RT-PCR
To quantitate the mRNA for RPE65 during development, we used
the competitive RT-PCR technique [21] in which the competitor was a
truncated mRNA fragment of RPE65 obtained by transcription of a
recombinant cDNA [22]. The strategy used to synthesize the compet-
itor RNA and the process of the competitive RT-PCR are illustrated
in Fig. 1.
To synthesize the competitor RNA, 2 Wg of whole eye total RNA
was reverse transcribed in a 10-Wl reaction volume containing 50 mM
Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCl2, 10 mM DTT, 500 WM
dNTPs, 0.5 WM of AS6 (5P-CTTTTGTCCTGCCCCAGG-3P), 12.5
units of Moloney murine reverse transcriptase and incubated at
37‡C for 1 h. Following inactivation of the reverse transcriptase at
68‡C for 20 min, a truncated recombinant cDNA was obtained by
PCR ampli¢cation of 1 Wl of cDNA diluted into a 20-Wl PCR reaction
mixture containing 75 mM Tris-HCl (pH 9.0), 20 mM (NH4)2SO4,
0.01% Tween 20, 1.5 mM MgCl2, 200 WM dNTPs, 1 unit of Taq DNA
polymerase and 25 pmol each of the forward primer (T7S1, Fig. 1)
bearing the T7 polymerase promoter sequence in 5P (5P-GCGCG-
TAATACGACTCACTATAGGGCGAATGTCAGGAGATACGTT-
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Fig. 1. Summary of the procedures followed for the synthesis of competitor RNA (A) and for the competitive RT-PCR (B). Sequences of T7S1
and recombinant reverse primer are given in Section 2.
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CTTCC-3P) and the recombinant reverse primer (RRP, Fig. 1) com-
posed of the juxtaposed AS6, AS7 and AS8 sequences (5P-
AGCAGGCTTTTGTCCTGCCCCAGGCTCACCACCACACTCAG-
AACTCAGCTTACACAACTTGTCTGG-3P). AS7 and AS8 are sep-
arated in the wild type mRNA by 105 nucleotides. In both T7S1 and
RRP, the insertion of additional nucleotides (underlined in the se-
quences above and white boxes in Fig. 1) was necessary to obtain
proper in vitro transcription of the recombinant cDNA and e⁄cient
reverse transcription of the competitor RNA in the subsequent steps.
The program used was: 95‡C/3 min, (95‡C/30 s, 57‡C/30 s, 72‡C/1
min)U2 cycles, (95‡C/30 s, 70‡C/30 s, 72‡C/1 min)U33 cycles. The
recombinant cDNA was puri¢ed on agarose gel and 100 ng was in
vitro transcribed at 37‡C for 30 min in a 20-Wl volume containing
40 mM Tris pH 8.0, 8 mM MgCl2, 2 mM spermidine, 50 mM
NaCl, 0.4 mM rNTPs, 30 mM DTT, 40 units of RNasin and 10 units
of T7 RNA polymerase. DNA was subsequently digested with 0.5
units of RNase free DNase at 37‡C for 15 min; the synthesized com-
petitor RNA was extracted with water-saturated phenol/chloroform
and precipitated in the presence of ammonium acetate. The compet-
itor RNA was ¢nally dissolved in water and quanti¢ed by UV spec-
trophotometry with a V260/V280 ratio between 1.90 and 2.10. The cor-
rect size of the competitor RNA was veri¢ed on agarose formaldehyde
gels. It was stored in aliquots at 370‡C.
For each stage of development, eight reaction tubes containing the
same amount of total RNA (1500 ng for the embryonic stages, 1000
ng from P1 to P5, 100 ng from P6 to P10 and 10 ng from P12 to P25)
and eight serial threefold dilutions (1 pg to 3U1034 pg) of the com-
petitor RNA were prepared as well as three control reactions contain-
ing either total RNA only, competitor RNA only, or no RNA. These
RNAs were reverse transcribed in a 2-Wl volume containing 0.1 WM of
the AS6 primer and 1.25 units of reverse transcriptase in the condi-
tions described above. Speci¢c recombinant and wild type RPE65
cDNAs, annealed with the same primers, were then ampli¢ed (Fig.
1) by adding to each reverse transcription tube 18 Wl of a PCR mix-
ture (see above for ionic and dNTP components) containing 0.5 WM
each of the forward S1 (5P-GTCAGGAGATACGTTCTTCC-3P) and
reverse AS7 (5P-CTCACCACCACACTCAGAACT-3P) primers using
the following program: 95‡C/3 min, (95‡C/30 s, 57‡C/30 s, 72‡C/1
min)U35 cycles, 72‡C/5 min. Amplicons from wild type RPE65
mRNA (384 bp) and competitor RNA (279 bp) were ¢nally separated
on 4% ethidium bromide-stained agarose gels in 1UTAE.
2.5. Quantitation of the RPE65 mRNA
The £uorescence intensity of the PCR products was determined by
measuring the densitometry of the DNA bands from negative photo-
graphs of gels using the TITN Answare software program (Alcatel,
France). Since comparisons and equivalence point determination in
competitive RT-PCR are based on molar amounts, the £uorescence
associated with the shorter product (279 bp) was corrected by multi-
plication by the ratio 384/279 to enable direct comparison of corrected
£uorescence intensity of the 279-bp band with the measured £uores-
cence intensity of the 384-bp band. The log10 of the ratio of the
corrected £uorescence of the competitor RNA to the £uorescence
intensity of the mRNA was then plotted as a function of the log10
of the number of copies of competitor RNA (60 498U102/pg) added
in each tube and the linear regression of this function calculated using
the Excel program (Microsoft Inc., USA). The equivalence point at
which the number of copies of messenger RNA equals that of com-
petitor RNA was ¢nally determined from the linear regression plot by
interpolation for a value of the log10 of the ratio of £uorescence
intensities of 0.
3. Results
3.1. Nucleotide and amino acid sequences of rat RPE65
The rat RPE65 cDNA is 2123 nt long and encodes, as in
human and bovine species, 533 amino acids (cDNA and ami-
no acid sequences are available in GenBank under accession
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Fig. 2. Quantitation of RPE65 mRNA at postnatal day 25. Competitive RT-PCR was performed as described in Fig. 1B. 10 ng of whole eye
total RNA were distributed in each of eight tubes along with serial threefold dilutions of competitor RNA starting from 60 498U102 copies (1
pg of RNA, dilution coe⁄cient 1) to 2766 copies (dilution coe⁄cient 2187). Ethidium bromide-stained agarose gel shows the cDNA fragments
obtained from wild type RPE65 mRNA (384 bp) and from the shorter, competitor RNA (279 bp). The dilution coe⁄cient of the competitor
RNA (1^2187) is indicated in each lane. Control ampli¢cations without competitor RNA (lane a), without whole eye total RNA (lane b) or
without any RNA (lane c) were included. Densitometry of cDNA fragments for dilutions 9, 27, 81 and 243 were measured and the log10 of the
ratio of the corrected (multiplied by 384/279) £uorescence of competitor cDNA over the £uorescence of the wild type cDNA was calculated.
The graph shows these data plotted as a function of the log10 of the number of copies of RNA added in each tube. The function of the linear
regression depicted in the graph (y = ax+b) and the determination coe⁄cient (r2) are indicated. Interpolation for the log10 of the ratio of £uo-
rescence intensities = 0 (equivalence point) gives a value of 144 891 copies/10 ng of total RNA.
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number AF035673). Rat and bovine, and rat and human ami-
no acid sequences are 94.0% and 94.5% identical, respectively.
Interestingly, rat and bovine, and rat and human sequences
are 73.5% and 67.3% identical in the 5P-UTR, and 70.8% and
74.3% identical in the 3P-UTR stretch, respectively. This is
particularly relevant in the 3P-UTR as a possible regulation
of translation exerted on this region has been suggested [7].
3.2. Quanti¢cation of RPE65 mRNA
E⁄cient ampli¢cation by RT-PCR from whole eye total
RNA using S1 and AS7 was ¢rst veri¢ed. Subsequently, a
105 nt-deleted recombinant cDNA fragment was obtained us-
ing T7S1 and RRP primers (Fig. 1). E⁄cient ampli¢cation of
this latter fragment with S1 and AS7, the primers used in
competition, was also veri¢ed. Northern blot analysis showed
that total RNA samples from various developmental stages
were not degraded (not shown).
Two independent series of total eye RNA extraction and
competitive RT-PCR were performed. For each series and
each developmental stage from E18 to P25, the £uorescence
of cDNA fragments resulting from ampli¢cation of wild type
RPE65 mRNA and of competitor RNA was measured and
the number of copies of mRNA per ng of total RNA calcu-
lated (Fig. 2). Copy numbers for each series and at each
developmental stage were then plotted against the develop-
ment time course in a semi-logarithmic scale (Fig. 3).
RPE65 mRNA was detected as early as E18 with 36 copies/
ng of total RNA. From late embryonic stages (E18 and E19),
mRNA levels increased about 10-fold to reach a mean value
of 226 þ 62 copies at P2. Subsequently, the levels of mRNA
were stable from P2 to P4 with even a slight decrease to
150 þ 29 copies at P4. Starting from P5, a second, 200-fold
increase in the accumulation of mRNA gradually brought the
level to 27 282 þ 1675 copies/ng at P12. From P10^P12 to later
stages, the levels in the mRNA remained stable with varia-
tions being less than one log magnitude.
4. Discussion
Using competitive RT-PCR, RPE65 mRNA was quanti¢ed
during the development of the retina in rat. RPE65 mRNA
was detectable as early as E18 and, from this stage, it was
found to gradually accumulate up to P10^P12. At this point,
it plateaued at about 1000-fold the level of the late embryonic
stages. This increase was interrupted for 3 days (P2^P4) dur-
ing which the levels of mRNA remained approximately stable.
In rat, the development of the RPE starts soon after optic
vesicle formation as evidenced by the presence of pigmented
cells in the outer layer of the retina at E13.5 [16]. These pig-
mented, di¡erentiating RPE cells divide actively. By E18,
most RPE cells have achieved a morphologically di¡erentiated
aspect with apical microvilli and numerous melanosomes at
all stages of maturity [16]. In the same time, mitotic activity
drops but does not cease completely [23]. After birth, the rat
RPE undergoes a second wave of division characterized by a
burst of acytokinetic mitosis starting at P2, peaking at P2^P3,
decreasing at P5 and virtually ending by P11 [23]. This second
wave leads to binucleation of most of RPE cells in the poste-
rior retina.
RPE65 mRNA accumulation parallels steps of RPE devel-
opment. Indeed, amounts of mRNA were found to be quan-
ti¢able ¢rst by E18 (RPE65 mRNA was detected at E17 but
the level was too low to be reliably quanti¢ed), indicating that
the RPE65 gene is already turned on when the ¢rst wave of
cell division is ending, the RPE displaying several of its spe-
ci¢c features. Starting from this timepoint, a 1000-fold in-
crease in the levels of mRNA that lasts about 2 weeks is
observable. This increase is unlikely to result from cell multi-
plication as mitotic activity from E18 to P1 is low and since
the second wave of division, from P2 to P11, only doubles the
number of nuclei, the uninucleated RPE cells entering the
mitotic cycle only once [23]. Rather, it suggests a sustained
transcriptional activity of the RPE65 gene. There is, however,
a transient arrest in the growing accumulation of mRNA from
P2 to P4 that coincides with the peak of the second wave of
RPE cell division. This probably re£ects a temporary release
of speci¢c transcriptional activity when RPE cells enter the
mitotic cycle. After P4, as many binucleated cells are formed
and cease mitotic activity, the increase resumes.
Although the RPE65 mRNA was found at prenatal stages,
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Fig. 3. Quantitation of RPE65 mRNA as a function of age. The graph shows the log10 of the number of copies of RPE65 mRNA per ng of
whole eye total RNA plotted against the age in days at embryonic (ED) and postnatal (PND) stages. Curves from ¢rst (open squares) and sec-
ond (crosses) series of RNA extraction and quantitation are indicated.
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the protein itself could not be detected before P4^P5 in few
RPE cells of the posterior retina [14]. This apparent delay
might simply be due to the sensitivity limit of protein detec-
tion with monoclonal antibodies on tissue sections, a certain
amount of RPE65 protein being necessary, which itself de-
pends on su⁄cient amounts of RPE65 mRNA. However, oth-
er factors may restrain the ¢nding of the RPE65 protein at
early stages. In fact it is at P5 that the endoplasmic reticulum,
the organelle in which the RPE65 protein is found, extensively
develops in the RPE cells [24]. Another possibility could be a
translational inhibition of the RPE65 mRNA before P4^P5.
Previous results have shown that RPE65 mRNA, although
present in RPE cultures, is not translated [7]. An interpreta-
tion of this result is that a factor which might control trans-
lation in vivo is lacking in culture. The fact that 3P-UTRs
from human, bovine and rat RPE65 mRNAs ([10] and our
results) are conserved suggest potential sites for regulation in
these mRNAs. This awaits precise description of such a con-
trol and the identi¢cation of factors e¡ectively regulating the
translation.
RPE65 mRNA accumulation seems to follow a timing
shared by certain genes in the outer retina during its develop-
ment. Indeed, the rat [25] and mouse [26] opsin mRNAs
undergo a rapid increase in their accumulation during the ¢rst
postnatal week and also reach a steady state level at P10^P12.
The rates of mRNA accumulation for RPE65 and opsin are
also quite similar since the rat mRNA for opsin increases
from 1 to 100% of the adult level from P2^P3 to P12 [25]
while that for RPE65 occurs from P4^P5 to P12. It is during
this 1^100% increase that the photoreceptor outer segments
appear and grow in the subretinal space, coinciding with the
extension of the RPE microvilli [17] and a greater capacity of
the RPE cells to phagocytize the outer segment tips [27]. In
bovine retina, it is also during the appearance and growth of
outer segments that mRNAs for several rod-speci¢c genes
increase from 1 to 100% of their adult value [28,29]. More-
over, this increase seems to be switched on at the same time
for cone and rod opsins [30], even though cones are born
earlier than rods [31].
Taken together, these observations suggest that common
elements control the activation of genes from di¡erent cell
types including rods, cones and RPE cells. The fact that, in
monkey retina, cell births in RPE and neuroretina demon-
strate a remarkable spatial and temporal correspondence
[32] is another indication of common factors controlling pro-
liferation and/or di¡erentiation in play in the outer retina.
Given that conserved cis-acting elements are found in the
promoter region of various photoreceptor genes [33] and
that parts of a single promoter can confer transcriptional
speci¢city to several cell types such as blue cones and cone
bipolar cells [34], it is plausible that elements are shared by
photoreceptor and RPE genes. In that respect, examination of
promoter sequences and speci¢cities of newly available RPE
genes will be of great interest.
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